Journal Home > Volume 10 , Issue 1

The aim of this investigation was to formulate, characterize and evaluate etoricoxib (ET) loaded polymeric nanoparticles for topical delivery. For nanoprecipitation method, ethyl cellulose (EC) was used as polymers. All the formulations were prepared by varying the drug and polymer concentrations. The obtained nanoparticles were evaluated for yield, drug content, entrapment efficiency, loading capacity and in-vitro drug release. Comparative study was performed among the formulations of ethyl cellulose. For the formulation of the gel, carbopol 934 was used as a gelling base. By comparison, F3 formulation of ethyl cellulose was found to be the best with the highest entrapment efficiency of 79.1%, the smallest mean particle diameter (538 nm), a higher stability (–43.8 mV) and the ability to control the release for 12 h with 87.1% drug release. F3 formulation was incorporated into gel F3G. Based on the results, it could be concluded that F3G formulation of etoricoxib topical gel prepared with ethyl cellulose was found to be more efficient with the highest spreadability of 41.22 g.cm/sec and was able to sustain the drug release for about 12 h with a cumulative release of 79.1%.


menu
Abstract
Full text
Outline
About this article

Formulation and Evaluation of Cox-2 Inhibitor (Etoricoxib) Loaded Ethyl Cellulose Nanoparticles for Topical Drug Delivery

Show Author's information Abbaraju Krishna Sailaja( )Naheed Begum
Department of Pharmaceutics, RBVRR Women's College of Pharmacy Affiliated to Osmania University, Barkatpura, Hyderabad, India

Abstract

The aim of this investigation was to formulate, characterize and evaluate etoricoxib (ET) loaded polymeric nanoparticles for topical delivery. For nanoprecipitation method, ethyl cellulose (EC) was used as polymers. All the formulations were prepared by varying the drug and polymer concentrations. The obtained nanoparticles were evaluated for yield, drug content, entrapment efficiency, loading capacity and in-vitro drug release. Comparative study was performed among the formulations of ethyl cellulose. For the formulation of the gel, carbopol 934 was used as a gelling base. By comparison, F3 formulation of ethyl cellulose was found to be the best with the highest entrapment efficiency of 79.1%, the smallest mean particle diameter (538 nm), a higher stability (–43.8 mV) and the ability to control the release for 12 h with 87.1% drug release. F3 formulation was incorporated into gel F3G. Based on the results, it could be concluded that F3G formulation of etoricoxib topical gel prepared with ethyl cellulose was found to be more efficient with the highest spreadability of 41.22 g.cm/sec and was able to sustain the drug release for about 12 h with a cumulative release of 79.1%.

Keywords: Nanoprecipitation, Zeta potential, Polymeric nanoparticles, Gel, Etoricoxib

References(21)

[1]

S.B. Jayaswal, M.P. Narmada, Targeted drug delivery system. The Eastern Pharmacist, 1990: 17-21.

[2]

M. Abhilash, Potential applications of nanoparticles. International Journal of Pharma and Bio Sciences, 2011, 1(1).

[3]

R. Bagul, V. Mahajan, and A. Dhake, New approaches in nanoparticulate drug delivery system - a review. International Journal of Current Pharmaceutical Research, 2012, 4(3): 29-38.

[4]
S.P. Vyas, R.K. Khar, Targeted and controlled drug delivery. Novel carrier systems. CBS Publication, 2002.
[5]

N. Jain, R. Jain, N. Thakur, et al., Nano technology: A safe and effective drug delivery system. Asian Journal of Pharmaceutical and Clinical Research, 2010, 3(3): 159-165.

[6]

K.S. Soppomath, T.M. Aminabhavi, A.R. Kulkarni, et al., Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release, 2001, 7: 1-20.

[7]
N. Shah, R.K. Mewada, and T. Shah, Application of biodegradable polymers in controlled drug delivery. Proceedings of the 2nd International Conference on Current Trends in Technology NUiCONE 2011. Ahmedabad, India, Dec. 8-10, 2011: 8-10.
[8]

S.K.R. Namasivayam, A.T.G. Robin, R.S.A. Bharani, et al., Biocompatible polymer coated bovine serum albumin nanoparticles incorporated Azithromycin preparation for the improved anti-bacterial activity against human pathogenic bacteria. World Journal of Pharmacy and Pharmaceutical Sciences, 2013, 2(5): 3094-3106.

[9]

B.K. Behera, S.K. Sahoo, R. Mohapatra, et al., Biodegradable and bioinspired polymers for pharmaceutical formulations and drug delivery: A brief review. World Journal of Pharmaceutical Research, 2012, 1(3): 591-625.

[10]
J. Allouche, R. Brayner, Synthesis of organic and bioorganic nanoparticles: An overview of the preparation methods. Nanomaterials: A danger or a promise? Springer-Verlag London, 2013: 27-74.
DOI
[11]

C.E. Mora-Huertas, H. Fessi, A. Elaissari, et al., Influence of process and formulation parameters on the formation of submicron particles by solvent displacement and emulsification-diffusion methods critical comparison. Advances in Colloid and Interface Science, 2011, 163: 90-122.

[12]

A. Mehrothra, J.K. Pandi, Critical process parameters evaluation of modified nanoprecipitation method on lomustine nanoparticles and cytostatic activity study on L132 human cancer cell line. J Nanomedicine and Nanotechnology, 2012, 3(8): 149.

[13]

E. Mora-Huertas, H. Fessi, and A. Elaissari, Polymer based nanocapsules for drug delivery. International Journal of Pharmaceuticals, 2010, 355: 113-142.

[14]

L.P. Kaur, T.K. Guleri, Topical gel: A recent approach for novel drug delivery. Asian Journal of Biomedical and Pharmaceutical Sciences, 2013, 3(17): 1-5.

[15]

S.S. Vasava, N.P. Chotai, and H.K. Patel, Formulation and evaluation of nanosuspension drug delivery system of etoricoxib. Pharma Science Monitor, 6(1): 10-27.

[16]

U. Bilthariya, N. Jain, V. Rajoriya, et al., Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib. Drug Dev Ind Pharm, 2015, 41(1): 95-104.

[17]

K.C. Patel, S. Pramanik, Formulation and characterization of mefenamic acid loaded polymeric nanoparticles. World Journal of Pharmacy and Pharmaceutical Sciences, 2014, 3(6): 1391-1405.

[18]
S.J. Kshirsagar, Nanoparticle for colon specific drug delivery system. Proceedings of the 3rd International Conference on Nanotek and Expo. Hampton Inn Tropicana, Dec. 2-3, 2013.
[19]

L. Banjare, N. Ghillare, Development of biocompatible nanoparticles for sustained topical delivery of Rutin. International Journal of Pharmaceutical & Biological Archives, 2012, 3(2): 326-332.

[20]

S. Sahu, S. Saraf, C. Kaur, et al., Biocompatible nanoparticles for sustained tropical delivery of anticancer phyto constituent Quercetin. Pakistan Journal of Biological Sciences, 2013, 16(13): 601-609.

[21]

R. Choudhary, L. Goswami, P. Kothiyal, et al., Preparation of nanoparticles loaded nasal gel of Mirtazapine for treatment of depression. Journal of Advanced Pharmaceutical Sciences, 2013, 3(2).

Publication history
Copyright
Rights and permissions

Publication history

Received: 20 October 2017
Accepted: 25 December 2017
Published: 26 January 2018
Issue date: March 2018

Copyright

© Abbaraju Krishna Sailaja, Naheed Begum.

Rights and permissions

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return